These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2256446

  • 1. Plasma exchange in Guillain-Barré syndrome: effect on anti-peripheral nerve myelin antibodies.
    Vedeler CA, Nyland H.
    Acta Neurol Scand; 1990 Aug; 82(2):147-9. PubMed ID: 2256446
    [Abstract] [Full Text] [Related]

  • 2. Clinical correlation with anti-peripheral-nerve myelin antibodies in Guillain-Barré syndrome.
    Koski CL, Gratz E, Sutherland J, Mayer RF.
    Ann Neurol; 1986 Jun; 19(6):573-7. PubMed ID: 3729311
    [Abstract] [Full Text] [Related]

  • 3. Electrophysiologic studies in the Guillain-Barré syndrome: effects of plasma exchange and antibody rebound.
    Rudnicki S, Vriesendorp F, Koski CL, Mayer RF.
    Muscle Nerve; 1992 Jan; 15(1):57-62. PubMed ID: 1732763
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Plasma exchange in patients with Guillain-Barré syndrome: clinical improvement in patients with serum IgG antibodies to peripheral nerve tissue.
    Nyland H, Vedeler CA, Matre R, Halvorsen K, Fagius J, Osterman PO, Janzen RW, Skre H.
    Int J Artif Organs; 1984 May; 7(3):133-6. PubMed ID: 6735503
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation.
    Koski CL, Humphrey R, Shin ML.
    Proc Natl Acad Sci U S A; 1985 Feb; 82(3):905-9. PubMed ID: 3856240
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Anti-GM1, anti-central myelin proteins, and anti-cardiolipin autoantibodies during plasma-exchange in Guillain-Barré syndrome (GBS).
    Matà S, Avanzi G, Lombardo R, Cepparone F, Pinto F, Lolli F.
    J Clin Apher; 1998 Feb; 13(4):155-62. PubMed ID: 9886794
    [Abstract] [Full Text] [Related]

  • 18. Complement-fixing antiperipheral myelin antibodies and C9 neoantigen in serum of patients with Guillain-Barré syndrome: quantitation, kinetics, and clinical correlation.
    Koski CL.
    Ann N Y Acad Sci; 1987 Feb; 505():319-25. PubMed ID: 3479928
    [No Abstract] [Full Text] [Related]

  • 19. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
    Vriesendorp FJ, Mishu B, Blaser MJ, Koski CL.
    Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.